Literature DB >> 31545374

Exploring the barriers and facilitators for the use of digital health technologies for the management of COPD: a qualitative study of clinician perceptions.

P Slevin1, T Kessie1, J Cullen2,3, M W Butler4,5, S C Donnelly2,3, B Caulfield1.   

Abstract

BACKGROUND: Digital health technology (DHT) promises to support patients and healthcare professionals (HCPs) to optimize the management of chronic obstructive pulmonary disease (COPD). However, there is a lack of evidence demonstrating the effectiveness of DHT for the management of COPD. One reason for this is the lack of user-involvement in the development of DHT interventions in COPD meaning their needs and preferences are rarely accounted for in the design phase. Although HCP adoption issues have been identified in relation to DHT, little is known about the challenges perceived by HCPs providing care to COPD patients. Therefore, this study aims to qualitatively explore the barriers and facilitators HCPs perceive for the use of DHT in the management of COPD.
METHODS: Participants (n = 32) were recruited using snowball sampling from two university hospitals and several general practitioner clinics. A semi-structured interview was conducted with each participant. NVivo 12 software was used to complete thematic analysis on the data.
RESULTS: Themes identified include: data quality; evidence-based care; resource constraints; and digital literacy presented as barriers; and facilitators include the following themes: digital health training and education; improving HCP digital literacy; and Personalized prescribing. Patient-centered approaches, such as pulmonary rehabilitation and shared decision-making were suggested as implementation strategies to ease the adoption of digital health for the management of COPD.
CONCLUSION: These findings contribute new insights about the needs and preferences of HCPs working in COPD regarding DHT. The findings can be used to help mitigate user-experience issues by informing the design of person-centered implementation and adoption strategies for future digital health interventions in COPD.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31545374     DOI: 10.1093/qjmed/hcz241

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

Review 1.  ERS International Congress 2021: highlights from the Allied Respiratory Professionals assembly.

Authors:  Lucy Robertson; Filipa Machado; Sebastian Rutkowski; Liliana Silva; Sabina Miranda; Ingeborg Farver-Vestergaard; Thomas Janssens; Karl P Sylvester; Chris Burtin; Andreja Šajnić; Joana Cruz
Journal:  ERJ Open Res       Date:  2022-05-23

2.  Barriers and Facilitators to the Adoption of Mobile Health Among Health Care Professionals From the United Kingdom: Discrete Choice Experiment.

Authors:  Simon Leigh; Liz Ashall-Payne; Tim Andrews
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-06       Impact factor: 4.773

3.  Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease.

Authors:  Adam Lewis; Ellena Knight; Matthew Bland; Jack Middleton; Esther Mitchell; Kate McCrum; Joy Conway; Elaine Bevan-Smith
Journal:  BMJ Open Respir Res       Date:  2021-03

4.  Understanding the Needs of a Mobile Phone-Based Telemonitoring Program for Pregnant Women at High Risk for Pre-Eclampsia: Interpretive Qualitative Description Study.

Authors:  Anam Shahil Feroz; Kristina De Vera; Nadia D Bragagnolo; Sarah Saleem; Zulfiqar Bhutta; Emily Seto
Journal:  JMIR Form Res       Date:  2022-02-24

Review 5.  Digital Facilitation to Support Patient Access to Web-Based Primary Care Services: Scoping Literature Review.

Authors:  Brandi Leach; Sarah Parkinson; Evangelos Gkousis; Gary Abel; Helen Atherton; John Campbell; Christopher Clark; Emma Cockcroft; Christine Marriott; Emma Pitchforth; Jon Sussex
Journal:  J Med Internet Res       Date:  2022-07-14       Impact factor: 7.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.